Trial intelligence / Profile preview

Alefacept in Palmar Plantar Pustulosis

NCT00301002Phase 2Completed

Sponsor
Guenther Dermatology Research Centre
Start
Jun 2005
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of alefacept in palmoplantar pustulosis (PPP), sponsored by Guenther Dermatology Research Centre. Started Jun 2005; status: completed.

02

Drugs

alefacept
03

Conditions

palmoplantar pustulosis (PPP)

Beyond the preview

Go deeper on NCT00301002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00301002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call